STK-001-DS-101 Monarch Study - An Open-Label Study to Investigate the Safety and Pharmacokinetics of Single Ascending Doses of Antisense Oligonucleotide STK-001 in Children and Adolescents with Dravet Syndrome (IND #140833)

Project: Research project

Project Details

StatusActive
Effective start/end date7/13/20 → 8/31/50

Funding

  • Stoke Therapeutics, Inc.